Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Clinical trial NCT07165886 · RECRUITING
Trial details
- NCT number
- NCT07165886
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2028-08-29
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.